Nav

Press Releases

Global Good and Motic Introduce Breakthrough AI-Powered Microscope to Fight Drug-Resistant Malaria

With machine learning technology, EasyScan GO automatically and accurately detects malaria parasites within minutes, providing important decision support to microscopists and enabling effective tracking of the mutating disease through standardized diagnoses. The future of automated quality diagnosis begins now.


Global Good and Element Inc. to Develop Biometric Identification Technology for Infants and Children

Powered by deep learning algorithms, a modern form of artificial intelligence, that use existing cameras on mobile devices, the biometric application could—for the first time—enable health systems to recognize and follow patients from birth to old age.


Technium and Intellectual Ventures Collaborate to Create Venture Backed Startups

The Invention Science Fund (ISF) Incubator, the new startup arm at Intellectual Ventures, and Utah-based Technium announced today a strategic relationship to accelerate the creation of high-impact technology startup companies.


GE, Global Good deal with Access Bio brings asymptomatic malaria rapid diagnostic tests to market.

Intellectual Ventures’ Global Good Fund and GE (NYSE: GE), have signed a licensing agreement with the diagnostics technology company Access Bio (KOSDAQ: 950130) to manufacture and distribute innovative diagnostic technologies that will help global health workers to more rapidly identify asymptomatic malaria in low-resource regions around the world.


Global Good and Biopromic Partner to Co-Develop Low-Cost Diagnostic to Detect Tuberculosis

The partnership will combine Global Good’s assay platform with Biopromic’s proprietary technologies in sample preparation and high-sensitivity antibodies to improve the accessibility of accurate TB testing in low- and middle-income countries.


Dominion Harbor Acquires Iconic Kodak Portfolio from Intellectual Ventures

Dominion Harbor Enterprises today announced the acquisition of over 1,000 patent families from Kodak’s iconic portfolio of patented technologies. This extensive portfolio has been acquired from Intellectual Ventures (IV).


On World Cancer Day, Global Good and QuantuMDx Partner to Combat Cervical Cancer

QuantuMDx Group announced an assay co-development and commercialization agreement with The Global Good Fund, managed by Intellectual Ventures, to develop a rapid, low-cost and mobile diagnostic test for the detection of human papillomavirus (HPV).


Intellectual Ventures Appoints Larry Froeber to Chief Financial Officer

Intellectual Ventures (IV) announces the promotion of senior vice president and deputy chief financial officer Larry Froeber to the chief financial officer role.


IV Announces Deal with Equitable IP Holdings

Intellectual Ventures (IV) announced the sale of a seminal portfolio of patents in the online gaming space to an affiliate of Equitable IP Holdings.


Global Good Fund, the Feinstein Institute and Sanguistat Announce New Bioelectronic Treatment Initia

The Global Good Fund, The Feinstein Institute for Medical Research at Northwell Health and Sanguistat, Inc, are partnering on clinical trials of the Neural Tourniquet to evaluate the efficacy of bioelectronic medicine in treating blood loss associated with postpartum hemorrhage.


Archives

Twitter | Follow Us »

It’s a simple question with an interesting scientific explanation: In @qz’s “I’ve Always Wondered,” we learn why ou… twitter.com/i/web/status/9…

Jan 21

Machines can already outplay us in chess, poker and other games, and now they are becoming better readers as well!… twitter.com/i/web/status/9…

Jan 20

We pride ourselves in serving as a community living room. And with #ScienceintheCity, we bring experts to discuss i… twitter.com/i/web/status/9…

Jan 19